B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

S1PR4

MOLECULAR TARGET

sphingosine-1-phosphate receptor 4

UniProt: O95977NCBI Gene: 86985 compounds

S1PR4 (sphingosine-1-phosphate receptor 4) is targeted by 5 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting S1PR4

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1fingolimod4.1160
2Ouabain1.102
3Flurandrenolone0.691
4pirenperone0.691
5Tripterygium0.691

About S1PR4 as a Drug Target

S1PR4 (sphingosine-1-phosphate receptor 4) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 5 compounds with documented S1PR4 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

S1PR4 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.